Autolus Therapeutics plc 10-Q filing
Filed 2026-05-14 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001730463-26-000065
- Form type
- 10-Q
- CIK
- 0001730463
- Primary document
- https://www.sec.gov/Archives/edgar/data/1730463/000173046326000065/autl-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Autolus Therapeutics plc.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $26.2M | - | - |
| Cost Of Revenue | $24.6M | - | - |
| Operating Income | $-59.5M | - | - |
| Net Income | $-71.6M | - | - |
| Eps Basic | -0.27 | - | - |
| Eps Diluted | -0.27 | - | - |
| Cash And Equivalents | $130.9M | - | - |
| Total Assets | $527.1M | - | - |
| Total Liabilities | $418.2M | - | - |
| Shareholders Equity | $108.8M | - | - |
| Operating Cash Flow | $-65.3M | - | - |
| Capital Expenditures | $2.7M | - | - |